Daniela Cota - Publications

Affiliations: 
INSERM, Rennes, Bretagne, France 
Area:
Energy Balance, Neuroendocrinology

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Miralpeix C, Reguera AC, Fosch A, Zagmutt S, Casals N, Cota D, Rodríguez-Rodríguez R. Hypothalamic endocannabinoids in obesity: an old story with new challenges. Cellular and Molecular Life Sciences : Cmls. 78: 7469-7490. PMID 34718828 DOI: 10.1007/s00018-021-04002-6  0.402
2021 Sighinolfi G, Clark S, Blanc L, Cota D, Rhourri-Frih B. Mass spectrometry imaging of mice brain lipid profile changes over time under high fat diet. Scientific Reports. 11: 19664. PMID 34608169 DOI: 10.1038/s41598-021-97201-x  0.323
2021 Marion C, Zizzari P, Denis RG, Hassouna R, Chebani Y, Leste-Lasserre T, Doat H, Le Pen G, Cota D, Noble F, Luquet S, Pantel J. The GhsrQ343X allele favors the storage of fat by acting on nutrient partitioning. The Journal of Endocrinology. PMID 34582357 DOI: 10.1530/JOE-20-0576  0.338
2021 Perino A, Velázquez-Villegas LA, Bresciani N, Sun Y, Huang Q, Fénelon VS, Castellanos-Jankiewicz A, Zizzari P, Bruschetta G, Jin S, Baleisyte A, Gioiello A, Pellicciari R, Ivanisevic J, Schneider BL, ... ... Cota D, et al. Central anorexigenic actions of bile acids are mediated by TGR5. Nature Metabolism. 3: 595-603. PMID 34031591 DOI: 10.1038/s42255-021-00398-4  0.342
2021 Castellanos-Jankiewicz A, Guzmán-Quevedo O, Fénelon VS, Zizzari P, Quarta C, Bellocchio L, Tailleux A, Charton J, Fernandois D, Henricsson M, Piveteau C, Simon V, Allard C, Quemener S, Guinot V, ... ... Cota D, et al. Hypothalamic bile acid-TGR5 signaling protects from obesity. Cell Metabolism. PMID 33887197 DOI: 10.1016/j.cmet.2021.04.009  0.407
2021 Quarta C, Claret M, Zeltser LM, Williams KW, Yeo GSH, Tschöp MH, Diano S, Brüning JC, Cota D. POMC neuronal heterogeneity in energy balance and beyond: an integrated view. Nature Metabolism. PMID 33633406 DOI: 10.1038/s42255-021-00345-3  0.316
2020 Zizzari P, He R, Falk S, Bellocchio L, Allard C, Clark S, Lesté-Lasserre T, Marsicano G, Clemmensen C, Perez-Tilve D, Finan B, Cota D, Quarta C. CB1 and GLP-1 Receptors Cross-Talk Provides New Therapies for Obesity. Diabetes. PMID 33144338 DOI: 10.2337/db20-0162  0.388
2020 Soty M, Vily-Petit J, Castellanos-Jankiewicz A, Guzman-Quevedo O, Raffin M, Clark S, Silva M, Gautier-Stein A, Cota D, Mithieux G. Calcitonin gene-related peptide-induced phosphorylation of STAT3 in arcuate neurons is a link in the metabolic benefits of portal glucose. Neuroendocrinology. PMID 32516785 DOI: 10.1159/000509230  0.359
2020 Tischmann L, Drummen M, Joris PJ, Gatta-Cherifi B, Raben A, Fogelholm M, Matias I, Cota D, Mensink RP, Westerterp-Plantenga MS, Adam TC. Effects of a High-Protein Diet on Cardiometabolic Health, Vascular Function, and Endocannabinoids-A PREVIEW Study. Nutrients. 12. PMID 32455987 DOI: 10.3390/Nu12051512  0.315
2020 Drummen M, Tischmann L, Gatta-Cherifi B, Cota D, Matias I, Raben A, Adam T, Westerterp-Plantenga M. Role of endocannabinoids in energy balance regulation in participants in the post-obese state - a PREVIEW study. The Journal of Clinical Endocrinology and Metabolism. PMID 32333763 DOI: 10.1210/Clinem/Dgaa193  0.437
2020 Quarta C, Cota D. Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice. International Journal of Obesity (2005). PMID 32317751 DOI: 10.1038/S41366-020-0577-8  0.393
2019 Quarta C, Fioramonti X, Cota D. POMC Neurons Dysfunction in Diet-induced Metabolic Disease: Hallmark or Mechanism of Disease? Neuroscience. PMID 31689486 DOI: 10.1016/J.Neuroscience.2019.09.031  0.451
2019 Tischmann L, Drummen M, Gatta-Cherifi B, Raben A, Fogelholm M, Hartmann B, Holst JJ, Matias I, Cota D, Mensink RP, Joris PJ, Westerterp-Plantenga MS, Adam TC. Effects of a High-Protein/Moderate-Carbohydrate Diet on Appetite, Gut Peptides, and Endocannabinoids-A Preview Study. Nutrients. 11. PMID 31546629 DOI: 10.3390/Nu11102269  0.429
2019 Mazier W, Saucisse N, Simon V, Cannich A, Marsicano G, Massa F, Cota D. mTORC1 and CB1 receptor signaling regulate excitatory glutamatergic inputs onto the hypothalamic paraventricular nucleus in response to energy availability. Molecular Metabolism. PMID 31420305 DOI: 10.1016/J.Molmet.2019.08.005  0.453
2019 Bouyakdan K, Martin H, Liénard F, Budry L, Taib B, Rodaros D, Chrétien C, Biron É, Husson Z, Cota D, Pénicaud L, Fulton S, Fioramonti X, Alquier T. The gliotransmitter ACBP controls feeding and energy homeostasis via the melanocortin system. The Journal of Clinical Investigation. 130. PMID 30938715 DOI: 10.1172/Jci123454  0.503
2018 Hutch CR, Trakimas DR, Roelofs K, Pressler J, Sorrell J, Cota D, Obici S, Sandoval DA. Oea Signaling Pathways and the Metabolic Benefits of Vertical Sleeve Gastrectomy. Annals of Surgery. PMID 30702457 DOI: 10.1097/Sla.0000000000003093  0.392
2018 Haissaguerre M, Ferriere A, Clark S, Guzman-Quevedo O, Tabarin A, Cota D. NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin. Frontiers in Pharmacology. 9: 527. PMID 29867515 DOI: 10.3389/Fphar.2018.00527  0.486
2018 Haissaguerre M, Ferrière A, Simon V, Saucisse N, Dupuy N, André C, Clark S, Guzman-Quevedo O, Tabarin A, Cota D. mTORC1-dependent increase in oxidative metabolism in POMC neurons regulates food intake and action of leptin. Molecular Metabolism. PMID 29699927 DOI: 10.1016/J.Molmet.2018.04.002  0.415
2018 André C, Catania C, Remus-Borel J, Ladeveze E, Leste-Lasserre T, Mazier W, Binder E, Gonzales D, Clark S, Guzman-Quevedo O, Abrous DN, Layé S, Cota D. mTORC1 pathway disruption abrogates the effects of the ciliary neurotrophic factor on energy balance and hypothalamic neuroinflammation. Brain, Behavior, and Immunity. PMID 29548998 DOI: 10.1016/J.Bbi.2018.03.014  0.507
2017 Javary J, Allain-Courtois N, Saucisse N, Costet P, Heraud C, Benhamed F, Pierre R, Bure C, Pallares-Lupon N, Do Cruzeiro M, Postic C, Cota D, Dubus P, Rosenbaum J, Benhamouche-Trouillet S. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. Gut. PMID 29074727 DOI: 10.1136/Gutjnl-2017-314208  0.325
2017 Ruiz de Azua I, Mancini G, Srivastava RK, Rey AA, Cardinal P, Tedesco L, Zingaretti CM, Sassmann A, Quarta C, Schwitter C, Conrad A, Wettschureck N, Vemuri VK, Makriyannis A, Hartwig J, ... ... Cota D, et al. Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages. The Journal of Clinical Investigation. PMID 29035280 DOI: 10.1172/Jci83626  0.512
2017 Cota D. The brain strikes back: Hypothalamic targets for peripheral CB1 receptor inverse agonism. Molecular Metabolism. 6: 1077-1078. PMID 29031708 DOI: 10.1016/J.Molmet.2017.07.003  0.304
2017 Quarta C, Clemmensen C, Zhu Z, Yang B, Joseph SS, Lutter D, Yi CX, Graf E, García-Cáceres C, Legutko B, Fischer K, Brommage R, Zizzari P, Franklin BS, Krueger M, ... ... Cota D, et al. Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity. Cell Metabolism. PMID 28943448 DOI: 10.1016/J.Cmet.2017.08.023  0.624
2017 Lau BK, Cota D, Cristino L, Borgland SL. Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits. Neuropharmacology. PMID 28579186 DOI: 10.1016/J.Neuropharm.2017.05.033  0.504
2017 Piazza PV, Cota D, Marsicano G. The CB1 Receptor as the Cornerstone of Exostasis. Neuron. 93: 1252-1274. PMID 28334603 DOI: 10.1016/J.Neuron.2017.02.002  0.38
2017 Simon V, Cota D. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future. European Journal of Endocrinology. PMID 28246151 DOI: 10.1530/Eje-16-1044  0.506
2017 Khlaifia A, Matias I, Cota D, Tell F. Nutritional status dependent endocannabinoid signalling regulates the integration of rat visceral information. The Journal of Physiology. PMID 28233325 DOI: 10.1113/Jp273484  0.433
2016 André C, Guzman-Quevedo O, Rey C, Rémus-Borel J, Clark S, Castellanos-Jankiewicz A, Ladeveze E, Leste-Lasserre T, Nadjar A, Abrous DN, Laye S, Cota D. Inhibiting Microglia Expansion Prevents Diet-induced Hypothalamic and Peripheral Inflammation. Diabetes. PMID 27903745 DOI: 10.2337/Db16-0586  0.452
2016 Hebert-Chatelain E, Desprez T, Serrat R, Bellocchio L, Soria-Gomez E, Busquets-Garcia A, Zottola AC, Delamarre A, Cannich A, Vincent P, Varilh M, Robin LM, Terral G, García-Fernández MD, Colavita M, ... ... Cota D, et al. A cannabinoid link between mitochondria and memory. Nature. PMID 27828947 DOI: 10.1016/J.Bbabio.2016.04.251  0.311
2015 Haissaguerre M, Cota D. [Role of the mTOR pathway in the central regulation of energy balance]. Biologie Aujourd'Hui. 209: 295-307. PMID 27021048 DOI: 10.1051/Jbio/2016009  0.513
2015 Bermudez-Silva FJ, Romero-Zerbo SY, Haissaguerre M, Ruz-Maldonado I, Lhamyani S, El Bekay R, Tabarin A, Marsicano G, Cota D. Cannabinoid CB1 receptors and mTORC1 signalling pathway interact to modulate glucose homeostasis. Disease Models & Mechanisms. PMID 26563389 DOI: 10.1242/Dmm.020750  0.426
2015 Mazier W, Saucisse N, Gatta-Cherifi B, Cota D. The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease. Trends in Endocrinology and Metabolism: Tem. 26: 524-37. PMID 26412154 DOI: 10.1016/J.Tem.2015.07.007  0.491
2015 Gatta-Cherifi B, Cota D. Endocannabinoids and Metabolic Disorders. Handbook of Experimental Pharmacology. 231: 367-91. PMID 26408168 DOI: 10.1007/978-3-319-20825-1_13  0.437
2015 Gatta-Cherifi B, Cota D. New insights on the role of the endocannabinoid system in the regulation of energy balance. International Journal of Obesity (2005). PMID 26374449 DOI: 10.1038/Ijo.2015.179  0.513
2015 Cardinal P, Bellocchio L, Guzmán-Quevedo O, André C, Clark S, Elie M, Leste-Lasserre T, Gonzales D, Cannich A, Marsicano G, Cota D. Cannabinoid type 1 (CB1) receptors on Sim1-expressing neurons regulate energy expenditure in male mice. Endocrinology. 156: 411-8. PMID 25456065 DOI: 10.1210/En.2014-1437  0.5
2015 Lu B, Diz-Chaves Y, Markovic D, Contarino A, Penicaud L, Fanelli F, Clark S, Lehnert H, Cota D, Grammatopoulos DK, Tabarin A. The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms. International Journal of Obesity (2005). 39: 408-17. PMID 25189177 DOI: 10.1038/Ijo.2014.164  0.303
2014 Cardinal P, André C, Quarta C, Bellocchio L, Clark S, Elie M, Leste-Lasserre T, Maitre M, Gonzales D, Cannich A, Pagotto U, Marsicano G, Cota D. CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin. Molecular Metabolism. 3: 705-16. PMID 25352999 DOI: 10.1016/J.Molmet.2014.07.004  0.465
2014 Haissaguerre M, Saucisse N, Cota D. Influence of mTOR in energy and metabolic homeostasis. Molecular and Cellular Endocrinology. 397: 67-77. PMID 25109278 DOI: 10.1016/J.Mce.2014.07.015  0.485
2014 Cota D. mTORC2, the "other" mTOR, is a new player in energy balance regulation. Molecular Metabolism. 3: 349-50. PMID 24944894 DOI: 10.1016/J.Molmet.2014.04.002  0.462
2014 Soria-Gómez E, Massa F, Bellocchio L, Rueda-Orozco PE, Ciofi P, Cota D, Oliet SH, Prospéro-García O, Marsicano G. Cannabinoid type-1 receptors in the paraventricular nucleus of the hypothalamus inhibit stimulated food intake. Neuroscience. 263: 46-53. PMID 24434770 DOI: 10.1016/J.Neuroscience.2014.01.005  0.466
2014 Binder E, Bermúdez-Silva FJ, Elie M, Leste-Lasserre T, Belluomo I, Clark S, Duchampt A, Mithieux G, Cota D. Leucine supplementation modulates fuel substrates utilization and glucose metabolism in previously obese mice. Obesity (Silver Spring, Md.). 22: 713-20. PMID 23894080 DOI: 10.1002/Oby.20578  0.474
2013 Bosier B, Bellocchio L, Metna-Laurent M, Soria-Gomez E, Matias I, Hebert-Chatelain E, Cannich A, Maitre M, Leste-Lasserre T, Cardinal P, Mendizabal-Zubiaga J, Canduela MJ, Reguero L, Hermans E, Grandes P, ... Cota D, et al. Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes. Molecular Metabolism. 2: 393-404. PMID 24327955 DOI: 10.1016/J.Molmet.2013.08.001  0.438
2013 Binder E, Bermúdez-Silva FJ, André C, Elie M, Romero-Zerbo SY, Leste-Lasserre T, Belluomo I, Duchampt A, Clark S, Aubert A, Mezzullo M, Fanelli F, Pagotto U, Layé S, Mithieux G, ... Cota D, et al. Leucine supplementation protects from insulin resistance by regulating adiposity levels. Plos One. 8: e74705. PMID 24086364 DOI: 10.1371/Journal.Pone.0074705  0.463
2013 Bellocchio L, Soria-Gómez E, Quarta C, Metna-Laurent M, Cardinal P, Binder E, Cannich A, Delamarre A, Häring M, Martín-Fontecha M, Vega D, Leste-Lasserre T, Bartsch D, Monory K, Lutz B, ... ... Cota D, et al. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade. Proceedings of the National Academy of Sciences of the United States of America. 110: 4786-91. PMID 23487769 DOI: 10.1073/Pnas.1218573110  0.406
2012 André C, Cota D. Coupling nutrient sensing to metabolic homoeostasis: the role of the mammalian target of rapamycin complex 1 pathway. The Proceedings of the Nutrition Society. 71: 502-10. PMID 22877732 DOI: 10.1017/S0029665112000754  0.387
2012 Matias I, Gatta-Cherifi B, Tabarin A, Clark S, Leste-Lasserre T, Marsicano G, Piazza PV, Cota D. Endocannabinoids measurement in human saliva as potential biomarker of obesity. Plos One. 7: e42399. PMID 22860123 DOI: 10.1371/Journal.Pone.0042399  0.428
2012 Cardinal P, Bellocchio L, Clark S, Cannich A, Klugmann M, Lutz B, Marsicano G, Cota D. Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice. Endocrinology. 153: 4136-43. PMID 22778221 DOI: 10.1210/En.2012-1405  0.511
2012 Gatta-Cherifi B, Matias I, Vallée M, Tabarin A, Marsicano G, Piazza PV, Cota D. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. International Journal of Obesity (2005). 36: 880-5. PMID 21844878 DOI: 10.1038/Ijo.2011.165  0.452
2012 Bermudez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. Journal of Psychopharmacology (Oxford, England). 26: 114-24. PMID 21824982 DOI: 10.1177/0269881111408458  0.552
2012 Matias I, Gatta-Cherifi B, Cota D. Obesity and the Endocannabinoid System: Circulating Endocannabinoids and Obesity Current Obesity Reports. 1: 229-235. DOI: 10.1007/S13679-012-0027-6  0.447
2011 Bajzer M, Olivieri M, Haas MK, Pfluger PT, Magrisso IJ, Foster MT, Tschöp MH, Krawczewski-Carhuatanta KA, Cota D, Obici S. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice. Diabetologia. 54: 3121-31. PMID 21987346 DOI: 10.1007/S00125-011-2302-6  0.642
2011 Cota D, Marsicano G. New fat and new neurons: endocannabinoids control neurogenesis in obesity (Commentary on Rivera et al.). The European Journal of Neuroscience. 33: 1575-6. PMID 21535244 DOI: 10.1111/J.1460-9568.2011.07684.X  0.378
2011 Catania C, Binder E, Cota D. mTORC1 signaling in energy balance and metabolic disease. International Journal of Obesity (2005). 35: 751-61. PMID 20877289 DOI: 10.1038/Ijo.2010.208  0.521
2011 Gatta-Cherifi B, Matias I, Vallee M, Tabarin A, Marsicano G, Piazza PV, Cota D. Synergistic post-prandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity Appetite. 57. DOI: 10.1016/J.Appet.2011.05.174  0.354
2010 Quarta C, Bellocchio L, Mancini G, Mazza R, Cervino C, Braulke LJ, Fekete C, Latorre R, Nanni C, Bucci M, Clemens LE, Heldmaier G, Watanabe M, Leste-Lassere T, Maitre M, ... ... Cota D, et al. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metabolism. 11: 273-85. PMID 20374960 DOI: 10.1016/J.Cmet.2010.02.015  0.531
2010 Bellocchio L, Lafenêtre P, Cannich A, Cota D, Puente N, Grandes P, Chaouloff F, Piazza PV, Marsicano G. Bimodal control of stimulated food intake by the endocannabinoid system. Nature Neuroscience. 13: 281-3. PMID 20139974 DOI: 10.1038/Nn.2494  0.412
2009 Villanueva EC, Münzberg H, Cota D, Leshan RL, Kopp K, Ishida-Takahashi R, Jones JC, Fingar DC, Seeley RJ, Myers MG. Complex regulation of mammalian target of rapamycin complex 1 in the basomedial hypothalamus by leptin and nutritional status. Endocrinology. 150: 4541-51. PMID 19628573 DOI: 10.1210/En.2009-0642  0.596
2009 Cota D, Sandoval DA, Olivieri M, Prodi E, D'Alessio DA, Woods SC, Seeley RJ, Obici S. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism. Obesity (Silver Spring, Md.). 17: 1641-5. PMID 19325539 DOI: 10.1038/Oby.2009.84  0.675
2009 Cota D. Mammalian target of rapamycin complex 1 (mTORC1) signaling in energy balance and obesity. Physiology & Behavior. 97: 520-4. PMID 19296907 DOI: 10.1016/J.Physbeh.2009.03.006  0.524
2008 Proulx K, Cota D, Woods SC, Seeley RJ. Fatty acid synthase inhibitors modulate energy balance via mammalian target of rapamycin complex 1 signaling in the central nervous system. Diabetes. 57: 3231-8. PMID 18776140 DOI: 10.2337/Db07-1690  0.658
2008 Cota D, Matter EK, Woods SC, Seeley RJ. The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7202-8. PMID 18614690 DOI: 10.1523/Jneurosci.1389-08.2008  0.69
2008 Woods SC, Seeley RJ, Cota D. Regulation of food intake through hypothalamic signaling networks involving mTOR. Annual Review of Nutrition. 28: 295-311. PMID 18429698 DOI: 10.1146/Annurev.Nutr.28.061807.155505  0.681
2008 Cota D. Role of the endocannabinoid system in energy balance regulation and obesity. Frontiers of Hormone Research. 36: 135-45. PMID 18230900 DOI: 10.1159/000115362  0.517
2008 Sandoval D, Cota D, Seeley RJ. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annual Review of Physiology. 70: 513-35. PMID 17988209 DOI: 10.1146/Annurev.Physiol.70.120806.095256  0.616
2008 Cota D, Matter E, Woods S, Seeley R. The role of hypothalamic mTORC1 signaling in diet-induced obesity Appetite. 51: 360. DOI: 10.1016/J.Appet.2008.04.061  0.659
2007 Cota D. CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health. Diabetes/Metabolism Research and Reviews. 23: 507-17. PMID 17683024 DOI: 10.1002/Dmrr.764  0.508
2007 Cota D, Proulx K, Seeley RJ. The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology. 132: 2158-68. PMID 17498509 DOI: 10.1053/J.Gastro.2007.03.049  0.614
2007 Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grübler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology. 148: 1574-81. PMID 17194743 DOI: 10.1210/En.2005-1649  0.355
2006 Cota D, Barrera JG, Seeley RJ. Leptin in energy balance and reward: two faces of the same coin? Neuron. 51: 678-80. PMID 16982412 DOI: 10.1016/J.Neuron.2006.09.009  0.536
2006 Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ. Hypothalamic mTOR signaling regulates food intake. Science (New York, N.Y.). 312: 927-30. PMID 16690869 DOI: 10.1126/Science.1124147  0.679
2006 Cota D, Tschöp MH, Horvath TL, Levine AS. Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Research Reviews. 51: 85-107. PMID 16364446 DOI: 10.1016/J.Brainresrev.2005.10.004  0.452
2006 Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrine Reviews. 27: 73-100. PMID 16306385 DOI: 10.1210/Er.2005-0009  0.453
2006 Tangalos EG, Cota D, Fujioka K. Complex Cardiometabolic Risk Factors: Impact, Assessment, and Emerging Therapies Journal of the American Medical Directors Association. 7: 1-10. DOI: 10.1016/J.Jamda.2006.06.003  0.457
2006 Cota D, Proulx K, Woods SC, Seeley RJ. Response [5] Science. 313: 1236+1238.  0.313
2005 Proulx K, Cota D, Castañeda TR, Tschöp MH, D'Alessio DA, Tso P, Woods SC, Seeley RJ. Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 289: R729-37. PMID 15879057 DOI: 10.1152/Ajpregu.00029.2005  0.62
2005 Cota D, Woods SC. The role of the endocannabinoid system in the regulation of energy homeostasis Current Opinion in Endocrinology and Diabetes. 12: 338-351. DOI: 10.1097/01.Med.0000178715.87999.69  0.57
2003 Cota D, Genghini S, Pasquali R, Pagotto U. Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity. Journal of Endocrinological Investigation. 26: 1041-4. PMID 14759080 DOI: 10.1007/Bf03348205  0.488
2003 Cota D, Marsicano G, Tschöp M, Grübler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thöne-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst AC, Pasquali R, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. The Journal of Clinical Investigation. 112: 423-31. PMID 12897210 DOI: 10.1172/Jci17725  0.488
2003 Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U. Endogenous cannabinoid system as a modulator of food intake. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 27: 289-301. PMID 12629555 DOI: 10.1038/Sj.Ijo.0802250  0.465
2003 Marsicano G, Cota D, Stalla GK, Pasquali R, Pagotto U, Lutz B. Cannabinoids in energy balance and prospectives in the therapy of obesity Current Medicinal Chemistry - Central Nervous System Agents. 3: 81-87. DOI: 10.2174/1568015033477839  0.404
Show low-probability matches.